Development and evaluation of an 18 F-labeled nanobody to target SARS-CoV-2's spike protein
COVID-19, caused by the SARS-CoV-2 virus, has become a global pandemic that is still present after more than two years. COVID-19 is mainly known as a respiratory disease that can cause long-term consequences referred to as long COVID. Molecular imaging of SARS-CoV-2 in COVID-19 patients would be a p...
Saved in:
Published in | Frontiers in nuclear medicine Vol. 2; p. 1033697 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!